Drug intelligence / Profile preview

Acufol D3

Development stage
Unknown
Lead developer
Acure Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Acufol D3 is an oral nutraceutical combination product developed and marketed by Acure Pharma, an Indian pharmaceutical company. It is formulated as a tablet containing a combination of folate (likely in the form of L-methylfolate) and Vitamin D3 (cholecalciferol). The product is indicated for the management of folate and vitamin D deficiencies and as a general nutritional supplement. Folate is a critical cofactor in the folate metabolic pathway, essential for DNA synthesis, methylation, and red blood cell formation. Vitamin D3 acts as an agonist at the Vitamin D receptor (VDR), playing a vital role in calcium absorption, bone health, and immune system modulation. Acufol D3 is part of Acure Pharma's portfolio of marketed branded formulations and is intended to correct or prevent nutritional deficiencies in patients.

Brand names
Acufol D3
Other names
Acufol-D3Acufol-D-3Acufol-D 3
02

Targets

VDR (Vitamin D receptor)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Acufol D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acufol D3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call